Haemonetics (HAE) Reports Q4 2026 Earnings Results and Insights
Published on 5/8/2026
AI Summary
Haemonetics (HAE) announced its Q4 2026 earnings, reporting a revenue increase of 10% year-over-year to $250 million. The company highlighted a net income of $30 million, translating to a P/E ratio of 20. This growth indicates strong demand in the healthcare sector. Analysts see potential for continued growth in the coming quarters as healthcare services expand.
Related News
Earnings
Savara (SVRA) CFO Executes 580,187 Options, Sells 394,528 Shares
Jun 27
Regulation
Abbott Laboratories (ABT) Faces Class-Action Lawsuit Over PediaSure
Jun 27
Markets
Medtronic (MDT) Tariff Impact Reduces Estimates to $250 Million
Jun 27
Earnings
Bruker Corporation (BRKR) Price Target Raised to $65 by JPMorgan
Jun 27